This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer or Pain
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The objectives of this work are threefold: 1. To evaluate the analgesic efficacy of CWI in women discharged within 23 hours of major breast cancer surgery 2. To evaluate objective indices of patient recovery following anaesthesia and surgery in a 23 hour model of care 3. To evaluate patient satisfaction with their care pathway

Provided treatments

  • Drug: Bupivacaine continuous infusion

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02897934. The sponsor of the trial is University College Cork and it is looking for 10 volunteers for the current phase.
Official trial title:
Continuous Wound Infiltration and 23 Hour Discharge Following Major Breast Cancer Surgery